CRSP
Price
$46.70
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
4.1B
44 days until earnings call
RXRX
Price
$5.03
Change
-$0.37 (-6.85%)
Updated
Jun 27 closing price
Capitalization
2.04B
45 days until earnings call
Interact to see
Advertisement

CRSP vs RXRX

Header iconCRSP vs RXRX Comparison
Open Charts CRSP vs RXRXBanner chart's image
CRISPR Therapeutics AG
Price$46.70
Change-$0.00 (-0.00%)
Volume$32.88K
Capitalization4.1B
Recursion Pharmaceuticals
Price$5.03
Change-$0.37 (-6.85%)
Volume$46.63M
Capitalization2.04B
CRSP vs RXRX Comparison Chart in %
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. RXRX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Buy and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (CRSP: $47.49 vs. RXRX: $5.03)
Brand notoriety: CRSP and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 679% vs. RXRX: 190%
Market capitalization -- CRSP: $4.1B vs. RXRX: $2.04B
CRSP [@Biotechnology] is valued at $4.1B. RXRX’s [@Biotechnology] market capitalization is $2.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RXRX is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 3 bullish TA indicator(s).

  • CRSP’s TA Score: 5 bullish, 4 bearish.
  • RXRX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than RXRX.

Price Growth

CRSP (@Biotechnology) experienced а +7.32% price change this week, while RXRX (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

CRSP is expected to report earnings on Aug 11, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4.1B) has a higher market cap than RXRX($2.04B). CRSP YTD gains are higher at: 20.655 vs. RXRX (-25.592). CRSP has higher annual earnings (EBITDA): -455.24M vs. RXRX (-524.77M). CRSP has more cash in the bank: 1.86B vs. RXRX (500M). RXRX has less debt than CRSP: RXRX (92.9M) vs CRSP (219M). RXRX has higher revenues than CRSP: RXRX (59.8M) vs CRSP (35M).
CRSPRXRXCRSP / RXRX
Capitalization4.1B2.04B201%
EBITDA-455.24M-524.77M87%
Gain YTD20.655-25.592-81%
P/E RatioN/AN/A-
Revenue35M59.8M59%
Total Cash1.86B500M371%
Total Debt219M92.9M236%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
79
SEASONALITY SCORE
1..100
42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPRXRX
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
84%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDINX52.110.26
+0.50%
Janus Henderson Overseas N
ICMVX13.220.05
+0.38%
Intrepid Capital Institutional
JMNCX13.020.03
+0.23%
JPMorgan Research Market Neutral C
RNWFX89.110.20
+0.22%
American Funds New World R5
DBMYX30.800.06
+0.20%
BNY Mellon Sm/Md Cp Gr Y

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+1.69%
BEAM - CRSP
72%
Closely correlated
-1.98%
RXRX - CRSP
71%
Closely correlated
-6.85%
NTLA - CRSP
65%
Loosely correlated
-0.52%
ALLO - CRSP
62%
Loosely correlated
-1.67%
PRME - CRSP
62%
Loosely correlated
-8.68%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-6.85%
CRSP - RXRX
72%
Closely correlated
+1.69%
BEAM - RXRX
64%
Loosely correlated
-1.98%
ABSI - RXRX
62%
Loosely correlated
-3.32%
ABCL - RXRX
59%
Loosely correlated
-3.48%
PRME - RXRX
57%
Loosely correlated
-8.68%
More